A study showed that miR-27a could inhibit the expression of FBXO45, leading to accumulation of the downstream substrates of FBXO45 and modulation of cancer initiation and progression, indicating that FBXO45 is a direct target of miR-27a30. This evidence concerns the gene FBXO45 and cancer.